Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27647832 | 0.83 | CA1 (0.40) | CA1CA2 | |
| SCHEMBL8396145 | 0.80 | CA1 (0.42) | CA1CA2CA9 | |
| SCHEMBL28649416 | 0.79 | CA1 (0.47) | CA1CA2TSHRMAPTTP53 | |
| SCHEMBL28751455 | 0.77 | TDP1 (0.32) | — | |
| SCHEMBL28705763 | 0.77 | TSHR (0.33) | TSHR | |
| SCHEMBL28648470 | 0.77 | CA1 (0.45) | CA1CA2TSHRMAPTTP53 | |
| SCHEMBL22578299 | 0.76 | CA1 (0.39) | CA1CA2CA9 | |
| SCHEMBL20743495 | 0.76 | MAPK1 (0.32) | — | |
| SCHEMBL9859458 | 0.76 | CA1 (0.34) | CA1CA2CA9 | |
| SCHEMBL27745824 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012066366-A1 | NEW SALTS SUITABLE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS | EGIS GYŐGYSZERGYÁR NYILVÁNOSAN MŰKÖDÖ RÉSZVÉNYTÁR-SASÁG (HU) | 2012-05-24 | — | — | WO | disclosed |
| WO-2011110876-A1 | NOVEL SALTS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2011-09-15 | — | — | WO | disclosed |